| Issue |
E3S Web Conf.
Volume 328, 2021
International Conference on Science and Technology (ICST 2021)
|
|
|---|---|---|
| Article Number | 01017 | |
| Number of page(s) | 5 | |
| Section | Chemical Engineering, Physical Characteristics, Water Treatment | |
| DOI | https://doi.org/10.1051/e3sconf/202132801017 | |
| Published online | 06 December 2021 | |
Benefits of Nanogold Injections to Treat Rheumatism Arthritis Complaints: A Case Study on Covid19 Clinical Test Volunteers
1 Chemistry Department, Universitas Negeri Surabaya, Kampus Ketintang Surabaya, Indonesia
2 Japanase Department, Universitas Negeri Surabaya, Kampus Lidahwetan Surabaya, Indonesia
* Corresponding author : titiktaufikurohmah@unesa.ac.id
The reduction in rheumatoid arthritis was measured by the decrease in the diameter of the joint swelling expressed in percent. The Covid-19 status was obtained from the results of the PCR Swab. The results show that in general, COVID-19 volunteers with complaints of rheumatic arthritis are satisfied with nanogold injections because they reduce pain. Health in general; temperature, blood pressure and average heart rate during clinical trials within the normal ranges of healthy people. Volunteers for clinical trials during treatment were declared negative for COVID-19. It is proven that nanogold injections increase the immunity of Covid-19 volunteers with complaints of rheumatic arthritis. As for rheumatic arthritis complaints in general, all volunteers experienced a decrease. The decrease in swelling diameter of each volunteer differed from one another in the range of 20-36%. With reduced volunteers can stand straight, walk normally and no longer hurt when the joints are pressed.
Key words: COVID-19 / nanogold injections / rheumatic arthritis
© The Authors, published by EDP Sciences, 2021
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.